Acronyms
- P - Drugs with approved pediatric dosing
Atorvastatin
Lipitor®, Atorvaliq®
Lipitor®, Atorvaliq®
Dosage forms
Tablet
- 10 mg
- 20 mg
- 40 mg
- 80 mg
Suspension (Atorvaliq®)
- 20 mg/5 ml
- Comes in 150 ml bottle
- Store at room temp
Dosing
High cholesterol (adults)
- Starting: 10 - 20 mg once daily
- Maintenance: 10 - 80 mg once daily
- Max: 80 mg once daily
- Patients who require LDL reductions ≥ 45% may start with 40 mg once daily
- Assess lipids as early as 4 weeks after initiation and adjust dose as necessary
- Tablets may be taken without regard to food. Atorvaliq should be taken on an empty stomach (1 hour before or 2 hours after a meal).
Heterozygous familial hypercholesterolemia (10 - 17 years old)
- Starting: 10 mg once daily
- Maintenance: 10 - 20 mg once daily
- Tablets may be taken without regard to food. Atorvaliq should be taken on an empty stomach (1 hour before or 2 hours after a meal).
Homozygous familial hypercholesterolemia (10 - 17 years old)
- Starting: 10 - 20 mg once daily
- Maintenance: 10 - 80 mg once daily
- Max: 80 mg once daily
- Assess lipids as early as 4 weeks after initiation and adjust dose as necessary
- Tablets may be taken without regard to food. Atorvaliq should be taken on an empty stomach (1 hour before or 2 hours after a meal).
Kidney disease
- No dose adjustment necessary
Liver disease
Studies
Generic / Price
- Tablets: YES/$
- Suspension (150 ml): NO/$$$$
Fluvastatin
Lescol®, Lescol XL®
Lescol®, Lescol XL®
Dosage forms
Capsule (Lescol®)
- 20 mg
- 40 mg
Tablet, extended-release (Lescol XL®)
- 80 mg
Dosing
High cholesterol (adults)
- Lescol
- Starting: 40 mg once daily in evening
- Maintenance: 20 - 80 mg/day
- Max: 80 mg/day
- For 80 mg/day dosing, give 40 mg twice a day
- For patients requiring LDL reduction of < 25%, a 20 mg starting dose may be used
- Do not open capsules
- May take without regard to food
- Lescol XL
- Dosing: 80 mg once daily
- Max: 80 mg once daily
- May take without regard to food
- Do not crush, cut, or chew tablet
Heterozygous familial hypercholesterolemia (pediatric patients 10 - 16 years old)
- Starting: 20 mg once daily in evening
- Maintenance: 20 - 80 mg/day
- Max: 80 mg/day
- For 80 mg dosing, give 40 mg capsule twice a day or one Lescol XL 80 mg tablet once daily
- Do not open capsules
- May take without regard to food
Kidney disease
- CrCl ≥ 30 ml/min: no dose adjustment necessary
- CrCl < 30 ml/min: has not been studied at doses greater than 40 mg; use caution
Liver disease
Generic / Price
- Lescol capsule - YES/$-$$
- Lescol XL tablet - YES/$$
Lovastatin
Mevacor®, Altoprev®
Mevacor®, Altoprev®
Dosage forms
Tablet (Mevacor®)
- 10 mg
- 20 mg
- 40 mg
Tablet, extended-release (Altoprev®)
- 20 mg
- 40 mg
- 60 mg
Dosing
High cholesterol (adults)
- Mevacor
- Starting: 20 mg once daily with evening meal
- Maintenance: 10 - 80 mg/day
- Max: 80 mg/day
- May be given once daily or in two divided doses
- Take with meals
- Altoprev
- Dosing: 20 - 60 mg once daily at bedtime
- Elderly: starting dose should be 20 mg
- Max: 60 mg once daily
- Take on an empty stomach. Food decreases absorption.
- Do not crush, cut, or chew tablet
Heterozygous Familial Hypercholesterolemia (pediatric patients 10 - 17 years old)
- Dosing: 10 - 40 mg/day
- Max: 40 mg/day
- For reductions in LDL of ≥ 20%, starting dose should be 20 mg/day. A starting dose of 10 mg/day may be considered for patients requiring smaller reductions.
- May be given once daily or in two divided doses
- Take with meals
Kidney disease
- CrCl ≥ 30 ml/min: no dose adjustment necessary
- CrCl < 30 ml/min: dosage increases above 20 mg /day should be carefully considered and, if deemed necessary, implemented cautiously
Liver disease
Generic / Price
- Tablet (Mevacor®): YES/$
- Tablet, extended-release (Altoprev®): NO/$$$$
Pitavastatin
Livalo®, Zypitamag®
Livalo®, Zypitamag®
Dosage forms
Tablet (Livalo®)
- 1 mg
- 2 mg
- 4 mg
Tablet (Zypitamag®)
- 2 mg
- 4 mg
Dosing
High cholesterol in adults (Livalo and Zypitamag)
- Starting: 2 mg once daily
- Maintenance: 1 - 4 mg once daily
- Max: 4 mg once daily
- May take without regard to food
Heterozygous familial hypercholesterolemia in pediatric patients ≥ 8 years old (Livalo)
- Starting: 2 mg once daily
- Maintenance: 1 - 4 mg once daily
- Max: 4 mg once daily
- May take without regard to food
Kidney disease (adults)
- CrCl < 60 ml/min: recommended starting dose is 1 mg once daily; do not exceed 2 mg/day
Liver disease
Generic / Price
- Livalo - YES/$-$$
- Zypitamag - NO/$$$$
Pravastatin
Pravachol®
Pravachol®
Dosage forms
Tablet
- 10 mg
- 20 mg
- 40 mg
- 80 mg
Dosing
High cholesterol (adults)
- Starting: 40 mg once daily
- Maintenance: 40 - 80 mg once daily
- Max: 80 mg once daily
- May take without regard to food
High cholesterol (adolescents 14 - 18 years)
- Dosing: 40 mg once daily
- Doses higher than 40 mg have not been studied in this population
- May take without regard to food
High cholesterol (children 8 - 13 years)
- Dosing: 20 mg once daily
- Doses higher than 20 mg have not been studied in this population
- May take without regard to food
Kidney disease
- CrCl < 30 ml/min: starting dose of 10 mg is recommended
Liver disease
Generic / Price
- YES/$
Rosuvastatin
Crestor®, Ezallor™ Sprinkle
Crestor®, Ezallor™ Sprinkle
Dosage forms
Tablet (Crestor®)
- 5 mg
- 10 mg
- 20 mg
- 40 mg
Capsule (Ezallor™ Sprinkle)
- 5 mg
- 10 mg
- 20 mg
- 40 mg
Dosing
High cholesterol (adults)
- Starting: 10 - 20 mg once daily
- Maintenance: 5 - 40 mg once daily
- Max: 40 mg once daily
- Asian patients: use a starting dose of 5 mg/day. Use caution if exceeding 20 mg/day. See statins in Asian patients for more.
- In patients with homozygous familial hypercholesterolemia, starting dose of 20 mg is recommended
- May take without regard to food
Heterozygous familial hypercholesterolemia (pediatric)
- 8 - 9 years: 5 - 10 mg once daily
- 10 - 17 years: 5 - 20 mg once daily
- May take without regard to food
Homozygous familial hypercholesterolemia (pediatric)
- 7 - 17 years: 20 mg once daily
- May take without regard to food
Kidney disease
- CrCl < 30 ml/min: recommended starting dose is 5 mg once daily. Do not exceed 10 mg/day.
Liver disease
Generic / Price
- Tablet - YES/$
- Capsule - NO/$$
Other
Ezallor™ Sprinkle
- Capsules should be swallowed whole. Do not crush or chew.
- Capsules may be opened and granules sprinkled on a teaspoon of soft food such as applesauce or chocolate/vanilla flavored pudding. Swallow whole without chewing within 60 minutes of combining.
- May be given via NG tube. See Ezallor PI for instructions.
Simvastatin
Zocor®, Flolipid®
Zocor®, Flolipid®
Dosage forms
Tablet (Zocor®)
- 5 mg
- 10 mg
- 20 mg
- 40 mg
- 80 mg
Suspension (Flolipid®)
- 20 mg/5 ml
- 40 mg/5 ml
- Comes in 150 ml bottle
- Store at room temperature
- Use within 30 days of opening
Dosing
High cholesterol (adults)
- Starting: 10 - 20 mg once daily in the evening
- Maintenance: 5 - 40 mg once daily
- Max: 40 mg once daily
- Asian patients: simvastatin may increase risk of myopathy. See statins in Asian patients for more.
- 80 mg dose should be limited to patients who have been taking it for ≥ 12 months without muscle toxicity
- The tablet may be taken without regard to food. The suspension should be taken in the evening on an empty stomach.
Heterozygous familial hypercholesterolemia (pediatric patients 10 - 17 years old)
- Starting: 10 mg once daily in the evening
- Maintenance: 10 - 40 mg once daily
- Max: 40 mg once daily
- The tablet may be taken without regard to food. The suspension should be taken in the evening on an empty stomach.
Kidney disease
- CrCl < 30 ml/min: recommended starting dose is 5 mg once daily
Liver disease
Generic / Price
- Zocor - YES/$
- Flolipid - NO/$$$$
Efficacy
Roszet®
Rosuvastatin + ezetimibe
Rosuvastatin + ezetimibe
Dosage forms
Tablet
- Rosuvastatin - Ezetimibe
- 5 mg - 10 mg
- 10 mg - 10 mg
- 20 mg - 10 mg
- 40 mg - 10 mg
Dosing
High cholesterol
- Dosing: 5/10 mg - 40/10 mg once daily
- Asian patients: starting dose should be 5/10 mg once daily. Consider risks/benefits of doses > 20/10 mg. Exposure to rosuvastatin is higher in Asian patients (see statins in Asian patients for more).
- Kidney disease:
- CrCl ≥ 30 ml/min: no dose adjustment necessary
- CrCl < 30 ml/min: recommended starting dose is 5/10 mg once daily. Do not exceed 10/10 mg once daily.
- May take without regard to food
- Do not crush, dissolve, or chew tablets
Generic / Price
- NO/$$$$
Vytorin®
Simvastatin + ezetimibe
Simvastatin + ezetimibe
Dosage forms
Tablet
- Ezetimibe - Simvastatin
- 10 mg - 10 mg
- 10 mg - 20 mg
- 10 mg - 40 mg
- 10 mg - 80 mg
Dosing
High cholesterol
- Starting: 10/10 - 10/20 mg once daily in the evening
- Maintenance: 10/10 - 10/40 mg once daily in the evening
- Max: 10/40 mg once daily
- May take without regard to food
- For patients requiring > 55% LDL reduction, recommended starting dose is 10/40 mg/day
- Due to increased risk of myopathy, the 10/80 mg dose should be restricted to patients who have been taking 10/80 mg chronically (> 12 months) without evidence of muscle toxicity
Generic / Price
- YES/$-$$
Caduet®
Amlodipine + atorvastatin
Amlodipine + atorvastatin
Dosage forms
Tablet
- Amlodipine - Atorvastatin
- 2.5 mg - 10 mg
- 2.5 mg - 20 mg
- 2.5 mg - 40 mg
- 5 mg - 10 mg
- 5 mg - 20 mg
- 5 mg - 40 mg
- 5 mg - 80 mg
- 10 mg - 10 mg
- 10 mg - 20 mg
- 10 mg - 40 mg
- 10 mg - 80 mg
Dosing
Hypertension / Hyperlipidemia
- Starting: 2.5/10 mg once daily
- Maintenance: 2.5/10 - 10/80 mg once daily
- Max: 10/80 mg once daily
- May take without regard to food
Generic / Price
- YES/$$
- Kidney disease
- Atorvastatin (Lipitor®)
- No dose adjustment necessary in kidney disease
- Fluvastatin (Lescol®)
- CrCl ≥ 30 ml/min: no dose adjustment necessary
- CrCl < 30 ml/min: has not been studied at doses greater than 40 mg; use caution
- Lovastatin (Mevacor®)
- CrCl ≥ 30 ml/min: no dose adjustment necessary
- CrCl < 30 ml/min: dosage increases above 20 mg /day should be carefully considered and, if deemed necessary, implemented cautiously
- Pitavastatin (Livalo®)
- CrCl < 60 ml/min: recommended starting dose is 1 mg once daily; do not exceed 2 mg/day
- Pravastatin (Pravachol®)
- CrCl < 30 ml/min: starting dose of 10 mg is recommended
- Rosuvastatin (Crestor®)
- CrCl < 30 ml/min: recommended starting dose is 5 mg once daily; do not exceed 10 mg/day
- Simvastatin (Zocor®)
- CrCl < 30 ml/min: recommended starting dose is 5 mg once daily
- Liver disease dosing
- Statins cause liver enzyme elevations in about 1.4% of patients and have been linked to rare cases of hepatotoxicity and liver failure. All statins used to list active liver disease as a contraindication, but recently, some labels have been updated to say acute liver failure or decompensated cirrhosis, as studies have found statins to be safe and possibly beneficial in some forms of stable liver disease. Recommendations from the AHA on statin use in liver disease are provided below. Guidance on monitoring liver enzymes is covered here - statins and hepatotoxicity. [7,8]
- AHA recommendations
- Statins appear to be safe to use and do not cause progression of liver disease in patients with fatty liver disease or chronic hepatitis C. On that basis, there is no need to avoid statin therapy in patients with stable chronic liver disease and normal or modestly elevated transaminases (up to 3 X ULN).
- There are no reliable data showing that statins are safe in advanced or decompensated liver disease [9]
STATIN INTENSITY CHART
High-intensity statin therapy (lowers LDL by ≥ 50%) |
Moderate-intensity statin therapy (lowers LDL by 30 - 49%) |
Low-intensity statin therapy (lowers LDL by < 30%) |
---|---|---|
|
|
|
PRICE ($) INFO
- $ = 0 - $50
- $$ = $51 - $100
- $$$ = $101 - $150
- $$$$ = > $151
- Pricing based on one month of therapy at standard dosing in an adult
- Pricing based on information from GoodRX.com®
- Pricing may vary by region and availability
BIBLIOGRAPHY
- Manufacturer's package insert
- 2 - PMID 20842109
- 3 - PMID 21109302
- 4 - PMID 27754879 - AHA statin interaction recommendations
- 5 - Seasonale PI
- 6 - PMID 30580575 - Statin Safety and Associated Adverse Events A Scientific Statement From the American Heart Association, Arterioscler Thromb Vasc Biol, (2019)
- 7 - PMID 20842109 - Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial, Am J gastroenterol (2011)
- 8 - PMID 21109302 - Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis, Lancet (2010)
- 9 - PMID 30580575 - Statin Safety and Associated Adverse Events A Scientific Statement From the American Heart Association, Arterioscler Thromb Vasc Biol, (2019)
- 10 - PMID 37471501 - 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines, Circulation (2023)